News
Zacks Investment Research on MSN3d
Regeneron (REGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 ReleaseThe market expects Regeneron (REGN) to deliver a year-over-year decline in earnings on lower revenues when it reports results ...
Shares of Regeneron Pharmaceuticals Inc. REGN slid 1.35% to $564.64 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.07% to ...
Shares of Regeneron Pharmaceuticals Inc. REGN slipped 4.06% to $634.14 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising ...
Data & APIs. Events. Premarket ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback